Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. (Q38680300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

meta-analysis

0 references

title

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

3 March 2020

main subject

fatty liver disease

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Zobair M Younossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Dinan Abdelatif

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Yousef Fazel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Linda Henry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mark Wymer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

22 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

73-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

3 March 2020

cites work

1 reference

7 January 2021

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

7 January 2021

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

1 reference

7 January 2021

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

1 reference

7 January 2021

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

7 January 2021

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

7 January 2021

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

1 reference

7 January 2021

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

7 January 2021

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

7 January 2021

Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies

1 reference

7 January 2021

Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia

1 reference

7 January 2021

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

1 reference

7 January 2021

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

1 reference

7 January 2021

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

1 reference

7 January 2021

Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.

1 reference

7 January 2021

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

1 reference

7 January 2021

NAFLD in Asia--as common and important as in the West

1 reference

7 January 2021

Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey

1 reference

7 January 2021

Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study.

1 reference

7 January 2021

Introduction to Meta-Analysis

1 reference

7 January 2021

Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China

1 reference

7 January 2021

The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population.

1 reference

7 January 2021

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population

1 reference

7 January 2021

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

1 reference

7 January 2021

Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study

1 reference

7 January 2021

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26707365%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference